The building, which is also adjacent to the Texas A&M Health Science Center’s Institute of Biosciences and Technology facility in Houston, will house Texas A&M’s engineering medical school, EnMed.
The EnMed program stems from a collaboration between Texas A&M and Houston Methodist Hospital. The goal of the initiative is to “educate a new kind of doctor who will create transformational technology for healthcare,” according to the Texas A&M news center.
The financial details of the transaction were not disclosed.
More articles on transactions and valuations:
Virginia health commissioner reportedly extends deadline for Wellmont, MSHA merger 1 month
Massena Memorial Hospital affiliation talks on hold
Meridian Behavioral Health Systems completes purchase of West Virginia hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
